Skip to main content
. Author manuscript; available in PMC: 2018 May 29.
Published in final edited form as: J Urol. 2017 Apr 28;198(4):780–786. doi: 10.1016/j.juro.2017.04.089

Table 1.

Patient demographics and final pathology. SD= standard deviation, RCC= renal cell carcinoma.

n= 110 patients (121 tumors)
Age, y (mean ± SD) 57 ± 14
Male/Female (%) 61/39%
Tumor size, cm (mean ± SD) 2.4 ± 0.8
Histology (%)
 Clear cell RCC 61 (50%)
 Papillary RCC 25 (21%)
 Chromophobe RCC 9 (7%)
 Other RCC 6 (5%)
 Oncocytoma 7 (6%)
 Angiomyolipoma 6 (5%)
 Other benign 7 (6%)
Final pathology
 pT1a 97 (96%)
 pT3a 4 (4%)
Fuhrman Grade
 1 6 (6%)
 2 72 (71%)
 3 15 (15%)
 4 0
 Unknown 8 (8%)